BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Pharm Country

  Argentum Succeeds In Starting Patent Cancellation Trial Against Janssen’s ZYTIGA

  September 19, 2016

   · 

  1 min read
• Business

  Madrigal Wrangles Cancer Deal Worth $163 Million+ Out of Massachusetts’ Tarveda

  September 19, 2016

   · 

  7 min read
• BioCapital

  Generic Pharmaceutical Association (GPhA) CEO To Hold Conference Call On Drug Costs, Increasing Generic Competition

  September 19, 2016

   · 

  1 min read
• BioCapital

  Evaluating FDA’s Approach To Cancer Clinical Trials

  September 19, 2016

   · 

  3 min read
• BioMidwest

  Spotlight Innovation Announces Debt Restructuring Through Conversion Of $850,000 In Convertible Promissory Notes

  September 19, 2016

   · 

  2 min read
• Drug Development

  NovaBay’ Auriclosene Demonstrates Statistically Significant And Clinically Meaningful Results In Phase 2b Study For The Prevention Of Urinary Catheter Blockage And Encrustation

  September 19, 2016

   · 

  7 min read
• Business

  Veristat Strengthens Its Long-Standing Relationship With Aegerion By Establishing A Preferred Provider Agreement

  September 19, 2016

   · 

  2 min read
• Policy

  BIO Statement On Biosimilar User Fee Act Goals Letter

  September 19, 2016

   · 

  3 min read
• Pharm Country

  Citius Pharma To Present At The 2016 Aegis Growth Conference

  September 19, 2016

   · 

  3 min read
• Genetown

  RXi Pharma To Present At The 16th Annual Biotech In Europe Forum For Global Partnering And Investment Conference

  September 19, 2016

   · 

  3 min read